New York [US], May 22: Lukka, the global leader in enterprise digital asset data and software solutions, proudly announces its acquisition of Coinfirm, a top-tier European based blockchain analytics software company. This acquisition deepens Lukka's existing capabilities to now support a com
Kolkata Knight Riders' (KKR) brilliant display of game against Sunrisers Hyderabad (SRH) in Qualifier 1 of IPL 2024 at Ahmedabad's Narendra Modi Stadium on Tuesday left every avid fan of the "team in purple" extremely happy. Like others, co-owner and Bollywood superstar Shah Rukh Khan cou
Birmingham researchers have proven PEPITEM, a naturally occurring peptide (small protein) has potential as a novel therapy for osteoporosis and other illnesses that entail bone loss, with specific advantages over conventional medications.
The Ministry of External Affairs hailed the development and said that it enables BIMSTEC to partner with other interested countries/organisations and admit Observers and new Members
He emphasized his commitment to social service, noting that his involvement is driven by a genuine desire to help, not as a means to ease his political entry.
In a whirlwind of dedication and determination, Bollywood actor Janhvi Kapoor is gearing up to enthral audiences with her upcoming Sharan Sharma directorial 'Mr & Mrs Mahi,' alongside RajKummar Rao.
Bollywood actor Aparshakti Khurana, known for his wit and humor, recently delighted fans with a fun video that blends motivation and entertainment, encouraging his followers to hit the gym with a positive attitude.
New Delhi [India], May 21: Mind Phenomenon is an outstanding science nonfiction by Professor Uttam Pati, an Emeritus Scientist, a biotechnologist, former Dean, School of Biotechnology, Jawaharlal Nehru University, New Delhi. The book is a profound journey into the enigmatic realm of the mind
Mumbai (Maharashtra) [India], May 21: Glenmark Specialty S.A. (Glenmark), a subsidiary of Glenmark Pharmaceuticals Ltd., a research-led, global pharmaceutical company, today announced an exclusive marketing and distribution agreement with BeiGene, a global oncology company. Under this agreem
Biocon Biologics announced that the U.S. Food and Drug Administration (US FDA) has approved the company's application for YESAFILI, the company informed the exchange in a filing.